Differential expression of Vibrio vulnificus capsular polysaccharide

Infection and Immunity

Volumn 67, Issue 5, 1999, Pages 2250-2257

  Wright, Anita C ^a   Powell, Jan L ^b   Tanner, Mike K ^c   Ensor, Lynne A ^b   Karpas, Arthur B ^d   Morris Jr , J Glenn ^b   Sztein, Marcelo B ^c  

^a UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c University of Maryland School of Medicine Center for Vaccine Development   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIUM MUTANT; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; RABBIT; TRANSPOSON; VIBRIO VULNIFICUS;

EID: 0032954438     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.5.2250-2257.1999     Document Type: Article

References (42)

1. Andreoni, C., L. Goetsch, C. Libon, P. Samuelson, T. N. Nguyen, A. Robert, M. Uhlen, H. Binz, and S. Stahl. 1997. Flow cytometric quantification of surface-displayed recombinant receptors on staphylococci. BioTechniques 23:696-702, 704.
2. Beck von Bodman, S., and S. K. Farrand. 1995. Capsular polysaccharide biosynthesis and pathogenicity in Erwinia stewartii require induction by an N-acylhomoserine lactone autoinducer. J. Bacteriol. 177:5000-5008.
3. Blake, P. A., M. H. Merson, R. E. Weaver, D. G. Hollis, and P. C. Heublein. 1979. Disease caused by a marine vibrio. Clinical characteristics and epidemiology. N. Engl. J. Med. 300:1-5.
4. Bush, C. A., P. Patel, S. Gunawardena, J. Powell, A. Joseph, J. A. Johnson, and J. G. Morris, Jr. 1997. Classification of Vibrio vulnificus strains by the carbohydrate composition of their capsular polysaccharides. Anal. Biochem. 250:186-195.
5. Carlsson, S. 1993. Isolation and characterization of glycoproteins, p. 1-26. In D. Rickwood and B. D. Hames (ed.), Glycobiology. Oxford University Press, New York, N.Y.
6. Claesson, B. A., R. Schneerson, J. B. Robbins, J. Johansson, T. Lagergard, J. Taranger, D. Bryla, L. Levi, T. Cramton, and B. Trollfors. 1989. Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate. J. Pediatr. 114:97-100.
7. Craven, D. E., M. S. Peppler, C. E. Frasch, L. F. Mocca, P. P. McGrath, and G. Washington. 1980. Adherence of isolates of Neisseria meningitidis from patients and carriers to human buccal epithelial cells. J. Infect. Dis. 142:556-568.
8. DePaola, A, G. M. Capers, and D. Alexander. 1994. Densities of Vibrio vulnificus in the intestines of fish from the U.S. Gulf Coast. Appl. Environ. Microbiol. 60:984-988.
9. Devi, S. J., U. Hayat, C. E. Frasch, A. S. Kreger, and J. G. Morris, Jr. 1995. Capsular polysaccharide-protein conjugate vaccines of carbotype 1 Vibrio vulnificus: construction, immunogenicity, and protective efficacy in a murine model. Infect. Immun. 63:2906-2911.
10. Devi, S. J. N., U. Hayat, J. L. Powell, and J. G. Morris, Jr. 1996. Preclinical immunoprophylactic and immunotherapeutic efficacy of antisera to capsular polysaccharide-tetanus toxoid conjugate vaccines of Vibrio vulnificus. Infect. Immun. 64:2220-2224.
11. Evans, M. E., M. Pollack, N. J, Hardegen, N. L. Koles, G. Guelde, and J. K. Chia. 1990. Fluorescence-activated cell sorter analysis of binding by lipopolysaccharide-specific monoclonal antibodies to gram-negative bacteria. J. Infect. Dis. 162:148-155.
12. Evans, M. E., M. Pollack, N. L. Koles, N. J. Hardegen, and D. Panopoulos. 1992. Lipopolysaccharide heterogeneity in Escherichia coli J5 variants: analysis by flow cytometry. J. Infect. Dis. 166:803-811.
13. Håkansson, S., S. E. Holm, and M. Wagner. 1987. Density profile of group B streptococci, type III, and its possible relation to enhanced virulence. J. Clin. Microbiol. 25:714-718.
14. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
15. Harris-Young, L., M. L. Tamplin, W. S. Fisher, and J. W. Mason. 1993 Effects of physicochemical factors and bacterial colony morphotype on association of Vibrio vulnificus with hemocytes of Crassostrea virginica. Appl. Environ. Microbiol. 59:1012-1017.
16. Hayat, U., G. P. Reddy, C. A. Bush, J. A. Johnson, A. C. Wright, and J. G. Morris, Jr. 1993. Capsular types of Vibrio vulnificus: an analysis of strains from clinical and environmental sources. J. Infect. Dis. 168:758-762.
17. Hitchcock, P. J., and T. M. Brown. 1983. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J. Bacteriol. 154:269-277.
18. Kreger, A. S., L. D. Gray, and J. Testa. 1984. Protection of mice against Vibrio vulnificus disease by vaccination with surface antigen preparations and anti-surface antigen antisera. Infect. Immun. 45:537-543.
19. Kroll, J. S., E. R. Moxon, and B. M. Loynds. 1993. An ancestral mutation enhancing the fitness and increasing the virulence of Haemophilus influenzae type b. J. Infect. Dis. 168:172-176.
20. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
21. Masson, L., and B. E. Holbein. 1985. Influence of nutrient limitation and low pH on serogroup B Neisseria meningitidis capsular polysaccharide levels: correlation with virulence for mice. Infect. Immun. 47:465-471.
22. Nelson, D., A. J. Bathgate, and L R. Poxton. 1991. Monoclonal antibodies as probes for detecting lipopolysaccharide expression on Escherichia coli from different growth conditions. J. Gen. Microbiol. 137:2741-2751.
23. Oliver, J. D., R. A. Warner, and D. R. Cleland. 1983. Distribution of Vibrio vulnificus and other lactose-fermenting vibrios in the marine environment. Appl. Environ. Microbiol. 45:985-998.
24. O'Neill, K., S. H. Jones, and D. J. Grimes. 1990. Incidence of Vibrio vulnificus in northern New England water and shellfish. FEMS Microbiol. Lett. 60:163-167.
25. Ou, J. T., L. S. Baron, F. A. Rubin, and D. J. Kopecko. 1988. Specific insertion and deletion of insertion sequence 1-like DNA element causes the reversible expression of the virulence capsular antigen Vi of Citrobacter freundii in Escherichia coli. Proc. Natl. Acad. Sci. USA 85:4402-4405.
26. Paoletti, L. C., R. A. Ross, and K. D. Johnson. 1996. Cell growth rate regulates expression of group B Streptococcus type III capsular polysaccharide. Infect. Immun. 64:1220-1226.
27. Reddy, G. P., U. Hayat, C. Abeygunawardana, C. Fox, A. C. Wright, D. R. Maneval, Jr., C. A. Bush, and J. G. Morris, Jr. 1992. Purification and determination of the structure of capsular polysaccharide of Vibrio vulnificus M06-24. J. Bacteriol. 174:2620-2630.
28. Rippey, S. R. 1994. Infectious diseases associated with molluscan shellfish consumption. Clin. Microbiol. Rev. 7:419-425.
29. Schneerson, R., L. Levi, J. B. Robbins, D. M. Bryla, G. Schiffman, and T. Lagergard. 1992. Synthesis of a conjugate vaccine composed of pneumococcus type 14 capsular polysaccharide bound to pertussis toxin. Infect. Immun. 60:3528-3532. (Erratum: 60:4443.)
30. Selinger, D. S., and W. P. Reed. 1979. Pneumococcal adherence to human epithelial cells. Infect. Immun. 23:455-458.
31. Sellin, M., S. Hakansson, and M. Norgren. 1995. Phase-shift of polysaccharide capsule expression in group B streptococci, type III. Microb. Pathog. 18:401-415.
32. Simpson, L. M., V. K. White, S. F. Zane, and J. D. Oliver. 1987. Correlation between virulence and colony morphology in Vibrio vulnificus. Infect. Immun. 55:269-272.
33. Sokal, R. R., and F. J. Rohlf. 1973. Introduction to biostatistics. W. H. Freeman, Co., San Francisco, Calif.
34. St. Geme, J. W. D., and S. Falkow. 1992. Capsule loss by Haemophilus influenzae type b results in enhanced adherence to and entry into human cells. J. Infect. Dis. 165(Suppl. 1):S117-S118.
35. Tamplin, M., G. E. Rodrick, N. J. Blake, and T. Cuba. 1982. Isolation and characterization of Vibrio vulnificus from two Florida estuaries. Appl. Environ. Microbiol. 44:1466-1470.
36. Vermeulen, C., A. Cross, W. R. Byrne, and W. Zollinger. 1988. Quantitative relationship between capsular content and killing of K1-encapsulated Escherichia coli. Infect. Immun. 56:2723-2730.
37. Wright, A. C., R. T. Hill, J. A. Johnson, M. C. Roghman, R. R. Colwell, and J. G. Morris, Jr. 1996. Distribution of Vibrio vulnificus in the Chesapeake Bay. Appl. Environ. Microbiol. 62:717-724.
38. Wright, A. C., L. M. Simpson, J. D. Oliver, and J. G. Morris, Jr. 1990. Phenotypic evaluation of acapsular transposon mutants of Vibrio vulnificus. Infect. Immun. 58:1769-1773.
39. 38a. Wright, A. C., et al. Unpublished data.
40. Yeung, M. K., and S. J. Mattingly. 1984. Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci. Infect. Immun. 44:217-221.
41. Yoshida, S., M. Ogawa, and Y. Mizuguchi. 1985. Relation of capsular materials and colony opacity to virulence of Vibrio vulnificus. Infect. Immun. 47:446-451.
42. Zerfas, P. M., M. Kessel, E. J. Quintero, and R. M. Weiner. 1997. Fine-structure evidence for cell membrane partitioning of the nucleoid and cytoplasm during bud formation in Hyphomonas species. J. Bacteriol. 179:148-156.